Business Description
Merck & Co Inc
NAICS : 325412
SIC : 2834
ISIN : ARDEUT110277
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.38 | |||||
Equity-to-Asset | 0.38 | |||||
Debt-to-Equity | 0.86 | |||||
Debt-to-EBITDA | 1.98 | |||||
Interest Coverage | 11.3 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 3.87 | |||||
Beneish M-Score | -2.72 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13 | |||||
3-Year EBITDA Growth Rate | -12.2 | |||||
3-Year EPS without NRI Growth Rate | -20.2 | |||||
3-Year FCF Growth Rate | 16.1 | |||||
3-Year Book Growth Rate | 14.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 82.92 | |||||
Future 3-5Y Total Revenue Growth Rate | 5.74 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 78.35 | |||||
9-Day RSI | 66.66 | |||||
14-Day RSI | 58.14 | |||||
6-1 Month Momentum % | -36.75 | |||||
12-1 Month Momentum % | 9.12 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.36 | |||||
Quick Ratio | 1.15 | |||||
Cash Ratio | 0.49 | |||||
Days Inventory | 151.53 | |||||
Days Sales Outstanding | 63.71 | |||||
Days Payable | 86.25 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.53 | |||||
Dividend Payout Ratio | 0.01 | |||||
3-Year Dividend Growth Rate | 6.1 | |||||
Forward Dividend Yield % | 2.84 | |||||
5-Year Yield-on-Cost % | 3.72 | |||||
Shareholder Yield % | 2.42 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 75.82 | |||||
Operating Margin % | 22.41 | |||||
Net Margin % | 19.23 | |||||
FCF Margin % | 28.74 | |||||
ROE % | 29.3 | |||||
ROA % | 11.06 | |||||
ROIC % | 16.16 | |||||
ROC (Joel Greenblatt) % | 60.04 | |||||
ROCE % | 17.83 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 21.31 | |||||
Forward PE Ratio | 0.24 | |||||
PE Ratio without NRI | 17.08 | |||||
Shiller PE Ratio | 26.28 | |||||
Price-to-Owner-Earnings | 25.36 | |||||
PS Ratio | 4.09 | |||||
PB Ratio | 5.78 | |||||
Price-to-Tangible-Book | 44.39 | |||||
Price-to-Free-Cash-Flow | 17.42 | |||||
Price-to-Operating-Cash-Flow | 14.15 | |||||
EV-to-EBIT | 18.48 | |||||
EV-to-Forward-EBIT | 9.43 | |||||
EV-to-EBITDA | 14.38 | |||||
EV-to-Forward-EBITDA | 8.77 | |||||
EV-to-Revenue | 4.38 | |||||
EV-to-Forward-Revenue | 4.07 | |||||
EV-to-FCF | 18.3 | |||||
Price-to-Projected-FCF | 1.55 | |||||
Price-to-Median-PS-Value | 0.93 | |||||
Price-to-Graham-Number | 5.81 | |||||
Earnings Yield (Greenblatt) % | 5.41 | |||||
FCF Yield % | 5.78 | |||||
Forward Rate of Return (Yacktman) % | 9.07 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Merck & Co Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ARS) | 48,832,641.329 | ||
EPS (TTM) (ARS) | 44971.849 | ||
Beta | 0 | ||
Volatility % | 59.26 | ||
14-Day RSI | 58.14 | ||
14-Day ATR (ARS) | 664.220614 | ||
20-Day SMA (ARS) | 22538.75 | ||
12-1 Month Momentum % | 9.12 | ||
52-Week Range (ARS) | 18840.5 - 38490 | ||
Shares Outstanding (Mil) | 252.96 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Merck & Co Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Merck & Co Inc Stock Events
Event | Date | Price(ARS) | ||
---|---|---|---|---|
No Event Data |
Merck & Co Inc Frequently Asked Questions
What is Merck & Co Inc(BUE:MRK)'s stock price today?
When is next earnings date of Merck & Co Inc(BUE:MRK)?
Does Merck & Co Inc(BUE:MRK) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |